In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives

Antimicrob Agents Chemother. 2008 Sep;52(9):3447-50. doi: 10.1128/AAC.00553-08. Epub 2008 Jul 14.

Abstract

In vitro treatment of Echinococcus multilocularis and Echinococcus granulosus larval stages with the antimalarials dihydroartemisinin and artesunate (10 to 40 microM) exhibited promising results, while 6 weeks of in vivo treatment of mice infected with E. multilocularis metacestodes (200 mg/kg of body weight/day) had no effect. However, combination treatments of both drugs with albendazole led to a substantial but statistically not significant reduction in parasite weight compared to results with albendazole alone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albendazole / pharmacology
  • Albendazole / therapeutic use
  • Animals
  • Anti-Infective Agents* / pharmacology
  • Anti-Infective Agents* / therapeutic use
  • Antiparasitic Agents / pharmacology
  • Antiparasitic Agents / therapeutic use
  • Artemisinins* / pharmacology
  • Artemisinins* / therapeutic use
  • Drug Therapy, Combination
  • Echinococcosis / drug therapy*
  • Echinococcosis / parasitology
  • Echinococcus granulosus / drug effects
  • Echinococcus granulosus / growth & development
  • Echinococcus multilocularis* / drug effects
  • Echinococcus multilocularis* / growth & development
  • Humans
  • Larva / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Nitro Compounds
  • Parasitic Sensitivity Tests
  • Thiazoles / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Antiparasitic Agents
  • Artemisinins
  • Nitro Compounds
  • Thiazoles
  • artenimol
  • artemisinin
  • Albendazole
  • nitazoxanide